Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study.
Tsunekazu MizushimaMasataka IkedaTakeshi KatoAtsuyo IkedaJunichi NishimuraTaishi HataChu MatsudaTaroh SatohMasaki MoriYuichiro DokiPublished in: BMC cancer (2019)
This clinical trial was registered in the University Hospital Medical Information Network registry system as UMIN000008634 at Aug 06, 2012.